1-2 of 2
Hideki Nagase
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of a Novel Combination Therapy, Based on Trifluridine/Tipiracil and Fruquintinib, against Colorectal Cancer

Open Access
Subject Area:
Topic Article Package: ADC (Antibody-Drug Conjugates) , Karger e-Journal Backfile Collection 2023 , Further Areas , Oncology , Pharmacology
Mamoru Nukatsuka, Akio Fujioka, Hideki Nagase, Gotaro Tanaka, Hiroaki Hayashi
Journal: Chemotherapy
Chemotherapy (2023) 68 (2): 102–110.
https://doi.org/10.1159/000528867
Published Online: 06 June 2023
View articletitled, Evaluation of a Novel Combination Therapy, Based on Trifluridine/Tipiracil and Fruquintinib, against Colorectal Cancer
Open the PDF for Evaluation of a Novel Combination Therapy, Based on Trifluridine/Tipiracil and Fruquintinib, against Colorectal Cancer in another window
Journal Articles

Antitumor Efficacy of Combination Therapy Consisting of S-1, Leucovorin, and Oxaliplatin against Human Gastric Cancer Xenografts

Available to Purchase
Subject Area:
Further Areas , Oncology , Pharmacology
Hideki Nagase, Fumio Nakagawa, Junji Uchida
Journal: Chemotherapy
Chemotherapy (2018) 63 (1): 46–52.
https://doi.org/10.1159/000486029
Published Online: 24 January 2018
View articletitled, Antitumor Efficacy of Combination Therapy Consisting of S-1, Leucovorin, and Oxaliplatin against Human Gastric Cancer Xenografts
Open the PDF for Antitumor Efficacy of Combination Therapy Consisting of S-1, Leucovorin, and Oxaliplatin against Human Gastric Cancer Xenografts in another window